Screener
Krystal Biotech, Inc. KRYS PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except par value) | March 31,2026 | December 31,2025 |
|---|---|---|
| Prepaid taxes | 10,642 | 14,006 |
| Prepaid expenses and other current assets | 16,026 | 14,905 |
| Total current assets | 1,019,741 | 1,024,602 |
| Property and equipment, net | 153,582 | 150,776 |
| Long-term investments | 193,485 | 128,066 |
| Right-of-use assets | 7,035 | 7,239 |
| Deferred tax asset, net of valuation allowance | 22,824 | 22,824 |
| Other non-current assets | 300 | 287 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s PP&E (net)?
- Krystal Biotech, Inc. (KRYS) reported PP&E (net) of $153.58M in Q1 2026.
- How has Krystal Biotech, Inc.'s PP&E (net) changed year-over-year?
- Krystal Biotech, Inc.'s PP&E (net) increased by 1.7% year-over-year, from $151.07M to $153.58M.
- What is the long-term trend for Krystal Biotech, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s PP&E (net) has grown at a 37.3% compound annual growth rate (CAGR), from $30.88M to $150.78M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Krystal Biotech, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude